Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.
about
Clinical Phenotypes in Heart Failure With Preserved Ejection FractionEvaluation of chronic kidney disease in chronic heart failure: From biomarkers to arterial renal resistancesWorsening renal function and outcome in heart failure patients with reduced and preserved ejection fraction and the impact of angiotensin receptor blocker treatment: data from the CHARM-study programme.A combined-biomarker approach to clinical phenotyping renal dysfunction in heart failureUrinary C-type natriuretic peptide: an emerging biomarker for heart failure and renal remodeling.The dose-dependent effect of nesiritide on renal function in patients with acute decompensated heart failure: a systematic review and meta-analysis of randomized controlled trialsAggravated Cardiac Remodeling post Aortocaval Fistula in Unilateral Nephrectomized Rats.Evidence of Mild Liver Dysfunction Identifies Stable Heart Failure Outpatients with Reversible Renal Dysfunction.The Prognostic Importance of Changes in Renal Function during Treatment for Acute Heart Failure Depends on Admission Renal Function.Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocIohexol clearance is superior to creatinine-based renal function estimating equations in detecting short-term renal function decline in chronic heart failure.eGFR and Outcomes in Patients with Acute Decompensated Heart Failure with or without Elevated BUN.Acute Kidney Injury in Pediatric Heart FailureThe risk of death associated with proteinuria in heart failure is restricted to patients with an elevated blood urea nitrogen to creatinine ratio.Galectin-3 in heart failure with preserved ejection fraction.Circulating biomarkers in patients with heart failure and preserved ejection fraction.Interplay of parathyroid hormone and aldosterone antagonist in prevention of heart failure hospitalizations in chronic kidney disease.Thyroid hormone and heart failure: from myocardial protection to systemic regulation.Heart failure with preserved ejection fraction: Defining the function of ROS and NO.The Basic Metabolic Profile in Heart Failure-Marker and Modifier.Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.Heart failure with preserved ejection fraction: a nephrologist-directed primer.Comparison of the Chronic Kidney Disease Epidemiology Collaboration, the Modification of Diet in Renal Disease study and the Cockcroft-Gault equation in patients with heart failure.Clinical implications of the CKD epidemiology collaboration (CKD-EPI) equation compared with the modification of diet in renal disease (MDRD) study equation for the estimation of renal dysfunction in patients with cardiovascular disease.Estimating glomerular filtration rate using the chronic kidney disease-epidemiology collaboration creatinine equation: better risk predictions.The Chronic Kidney Disease Epidemiology Collaboration equation outperforms the Modification of Diet in Renal Disease equation for estimating glomerular filtration rate in chronic systolic heart failure.Renal risk stratification in left ventricular assist device therapy.Inverse Relationship Between Serum Bilirubin Levels and Diabetic Foot in Chinese Patients with Type 2 Diabetes Mellitus.Heart Failure and Kidney Disease.Real-Life Use of Neurohormonal Antagonists and Loop Diuretics in Chronic Heart Failure: Analysis of Serial Biomarker Measurements and Clinical Outcome.Influence of renal impairment on aldosterone status, calcium metabolism, and vasopressin activity in outpatients with systolic heart failure.Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.Prognostic value of glomerular filtration rate estimation equations in acute heart failure with preserved versus reduced ejection fraction.Renal function in heart failure: a disparity between estimating function and predicting mortality risk.Relationship of renal insufficiency and clinical features or comorbidities with clinical outcome in patients hospitalised for acute heart failure syndromes.Preoperative right heart hemodynamics predict postoperative acute kidney injury after heart transplantation.
P2860
Q28073079-07CEB424-EE55-485A-8835-683A60A7D9F5Q28084462-2B8263FE-CD8B-462C-97F2-5CF245A0F0CBQ31115364-581D7B94-810D-4D0B-8FCA-091A8CC1E21AQ34937242-40C0AE08-1C39-4403-8383-2543F5FBE6EFQ35538390-7A9F1334-3D0D-4FD2-A5D4-B177869BE17DQ35672997-FDF9A921-DFF0-41DA-B13F-B5BDCAB3D911Q35739854-5656D46B-FF01-4BC3-8C5B-84F7D98BFB1BQ35773130-CC72F03A-EC66-4BC9-B629-1B006DE9C491Q35779122-569B5306-2CF1-47FE-8534-2B0817D82A85Q36188016-03688549-EB36-436A-BF54-04E0114B04DCQ36453374-4C391E67-547B-4F92-B4E6-5924ED874B3CQ36686994-0B6D0152-039D-4C68-B796-74DB3CA91BDEQ36886257-4220F7AD-1725-4DF1-B044-57F90F46C7CCQ37179961-69B0F8EC-021F-4CCC-A199-BB6016A77087Q38104695-B28CD6F8-F06B-4A19-93FE-12B22D53B6E4Q38152289-BACEE1E2-7D73-45E5-A000-B3FB8DA63CACQ38227113-31B249BF-CE35-411D-B15E-CA87831FA09AQ38249121-E00D0AF7-A535-41D5-8A71-C3425EDC95C2Q38482322-7902298C-58AB-4945-9CA5-FE0C62B05F89Q38694908-574213D7-3E0C-401F-9324-7D0D4CA63960Q38727741-4EBB4A5D-8428-47D3-A487-EFFBEB04DC57Q39301622-3982E58C-A2AA-45F0-9A44-721486C15699Q40100257-740D63D7-544E-49A8-8E37-BD45072FC04CQ40784158-DBDA5A21-40EE-44D3-8A56-C9B99AE2B8B2Q43209512-512B5A45-CBB9-42AC-B17B-54A4FAC5EBF3Q45768858-B9127DEF-7B03-42B4-AFF7-9CE6AC4A7E8BQ47239698-62A1095C-22CF-457D-A7F6-6D3038380467Q47240317-981B6339-F3D0-4876-8CDB-4DD03877DF72Q47437642-0FA39F11-2E25-4EBA-A9AA-09A37A72FBB1Q47438578-E6ECA584-26A5-4971-BEE9-D4825EF6A296Q47575429-021CE6A1-7214-43B2-861A-BAC1DB864407Q48725493-7D5DE26E-0901-44DC-B1AD-C63D383ECF89Q50963368-8437A7D5-47F8-4895-92C0-AD18754AC6B4Q51253282-1F09CA3E-FE81-46AF-9382-354F5FDF98A4Q54601825-4990A1D3-D5AD-4795-BD3F-7AEAA1E1415EQ55417560-99900C79-B432-41C5-BCB2-A32EF2CA4D1A
P2860
Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Renal dysfunction in patients ...... y Collaboration Group formula.
@en
Renal dysfunction in patients ...... y Collaboration Group formula.
@nl
type
label
Renal dysfunction in patients ...... y Collaboration Group formula.
@en
Renal dysfunction in patients ...... y Collaboration Group formula.
@nl
prefLabel
Renal dysfunction in patients ...... y Collaboration Group formula.
@en
Renal dysfunction in patients ...... y Collaboration Group formula.
@nl
P2093
P50
P921
P1476
Renal dysfunction in patients ...... y Collaboration Group formula.
@en
P2093
Finlay A McAlister
Iain Squire
Katrina K Poppe
Luigi Tarantini
Meta-analysis Global Group in Chronic Heart Failure (MAGGIC) Investigators
Nikki Earle
Robert N Doughty
P304
P356
10.1161/CIRCHEARTFAILURE.111.966242
P577
2012-03-22T00:00:00Z